Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
1-Year Return 51.86%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
+0.8%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$56.1B
AUM Growth
-$763M
Cap. Flow
-$463M
Cap. Flow %
-0.83%
Top 10 Hldgs %
48.8%
Holding
206
New
9
Increased
66
Reduced
73
Closed
13

Sector Composition

1 Consumer Discretionary 33.88%
2 Communication Services 19.56%
3 Healthcare 12.38%
4 Financials 9.29%
5 Technology 7.21%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PLX icon
176
Protalix BioTherapeutics
PLX
$127M
$4.07M 0.01%
636,136
-4,474
-0.7% -$28.6K
POWI icon
177
Power Integrations
POWI
$2.51B
$4.04M 0.01%
161,360
SKM icon
178
SK Telecom
SKM
$8.32B
$3.91M 0.01%
113,554
+18,635
+20% +$642K
REGN icon
179
Regeneron Pharmaceuticals
REGN
$60.1B
$3.53M 0.01%
10,100
ADAP
180
Adaptimmune Therapeutics
ADAP
$13.5M
$3.5M 0.01%
429,700
KDNY
181
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$3.28M 0.01%
58,000
+12,000
+26% +$679K
FMI
182
DELISTED
Foundation Medicine, Inc.
FMI
$3.26M 0.01%
174,800
ARMH
183
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$3.25M 0.01%
71,451
WIT icon
184
Wipro
WIT
$28.6B
$3.05M 0.01%
1,315,131
-1,362,720
-51% -$3.16M
RIO icon
185
Rio Tinto
RIO
$101B
$2.21M ﹤0.01%
70,626
ONC
186
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.1B
$2.03M ﹤0.01%
68,200
+66,350
+3,586% +$1.98M
HCM icon
187
HUTCHMED
HCM
$2.55B
$1.97M ﹤0.01%
+149,810
New +$1.97M
BIOA
188
DELISTED
BioAmber Inc.
BIOA
$1.73M ﹤0.01%
579,540
ACTG icon
189
Acacia Research
ACTG
$322M
$1.61M ﹤0.01%
365,820
LXFT
190
DELISTED
Luxoft Holding, Inc.
LXFT
$1.48M ﹤0.01%
+28,430
New +$1.48M
FOMX
191
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.39M ﹤0.01%
219,400
VALE.P
192
DELISTED
Vale S A
VALE.P
$1.3M ﹤0.01%
323,000
SNMX
193
DELISTED
Senomyx, Inc.
SNMX
$334K ﹤0.01%
121,665
-456,335
-79% -$1.25M
BRK.B icon
194
Berkshire Hathaway Class B
BRK.B
$1.09T
-41,243
Closed -$5.85M
EBAY icon
195
eBay
EBAY
$42.5B
-8,814,111
Closed -$210M
EFA icon
196
iShares MSCI EAFE ETF
EFA
$65.9B
-10,868
Closed -$621K
EHC icon
197
Encompass Health
EHC
$12.5B
-9,151
Closed -$15K
ETSY icon
198
Etsy
ETSY
$5.17B
-485,000
Closed -$4.22M
IWF icon
199
iShares Russell 1000 Growth ETF
IWF
$118B
-147,863
Closed -$14.8M
LC icon
200
LendingClub
LC
$1.92B
-6,924,099
Closed -$287M